McCulloch Kevin bought XERS
March 12, 2026 · Form 4 insider transaction
McCulloch Kevin bought 48,894 shares of Xeris Biopharma Holdings, Inc. at $4.09 per share, a transaction worth $200.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
48,894
Price
$4.09
Total value
$200.0K
InsiderMcCulloch Kevin
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 12, 2026
Filing dateMarch 16, 2026
Shares owned after1,777,721
OwnershipDirect
10b5-1 planNo
AmendedNo